Omega Therapeutics, Inc. (OMGA)

Omega Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	30.38	68.44	70.62	186.48	22.95	2.27
Short-Term Investments	-	4.99	54.06	38.85	-	-
Cash & Short-Term Investments	30.38	73.43	124.68	225.33	22.95	2.27
Cash Growth	-65.98%	-41.11%	-44.67%	881.77%	909.28%	-
Accounts Receivable	0.49	6.13	0.62	0.26	-	-
Other Receivables	-	0.86	1.18	0.26	0.19	0.01
Receivables	0.49	6.99	1.8	0.52	0.19	0.01
Prepaid Expenses	8.09	9.17	10.96	3.3	0.78	0.28
Other Current Assets	-	0.3	0.16	0.14	0.08	0.1
Total Current Assets	38.95	89.88	137.59	229.29	24	2.65
Property, Plant & Equipment	113.74	114.05	7.86	3.61	3.48	2.83
Other Long-Term Assets	0.03	0.44	0.55	0.44	0.6	0.63
Total Assets	152.73	204.37	146	233.33	28.08	6.12
Accounts Payable	1.43	1.62	3.11	2.11	1.06	0.92
Accrued Expenses	4.65	8.21	13.96	9.58	3.47	1.15
Current Portion of Long-Term Debt	4	4	3.33	-	3	-
Current Portion of Leases	11.92	11.3	1.52	-	-	-
Other Current Liabilities	2.17	1.67	0.04	0.29	0.17	0.17
Total Current Liabilities	24.17	26.81	21.96	11.98	7.7	2.23
Long-Term Debt	11.59	14.89	16.6	19.87	8.73	11.89
Long-Term Leases	100.63	98.24	1.12	-	-	-
Other Long-Term Liabilities	4.8	6.42	0.34	0.85	1.06	1.21
Total Liabilities	141.18	146.35	40.03	32.71	17.49	15.33
Common Stock	0.06	0.06	0.05	0.05	0.01	0.02
Additional Paid-In Capital	399	392.61	343.61	335.15	1.59	0.84
Retained Earnings	-387.51	-334.63	-237.21	-134.51	-66.23	-36.78
Comprehensive Income & Other	-	-0.01	-0.48	-0.06	-	-
Total Common Equity	11.54	58.02	105.97	200.63	-64.63	-35.92
Shareholders' Equity	11.54	58.02	105.97	200.63	10.6	-9.21
Total Liabilities & Equity	152.73	204.37	146	233.33	28.08	6.12
Total Debt	128.13	128.43	22.58	19.87	11.73	11.89
Net Cash (Debt)	-97.76	-55	102.1	205.46	11.22	-9.62
Net Cash Growth	-	-	-50.31%	1731.34%	-	-
Net Cash Per Share	-1.77	-1.02	2.13	9.17	2.87	-2.90
Filing Date Shares Outstanding	55.37	55.15	48.1	47.81	4.47	3.32
Total Common Shares Outstanding	55.16	55.14	48.07	47.79	4.47	3.32
Working Capital	14.78	63.08	115.63	217.3	16.3	0.43
Book Value Per Share	0.21	1.05	2.20	4.20	-14.47	-10.82
Tangible Book Value	11.54	58.02	105.97	200.63	-64.63	-35.92
Tangible Book Value Per Share	0.21	1.05	2.20	4.20	-14.47	-10.82
Machinery	-	9.5	7.4	6.02	4.56	3.02
Construction In Progress	-	0.59	0.83	0.05	0.02	-
Leasehold Improvements	-	1.29	1.38	1.38	1.38	1.2

Source: S&P Capital IQ. Standard template. Financial Sources.